Ally Bridge Group (Ny) LLC Moon Lake Immunotherapeutics Transaction History

Ally Bridge Group (Ny) LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$36.35 - $63.02 $1.44 Million - $2.5 Million	-39,626 Reduced 21.64%	143,479 $8.66 Million
Q3 2023 Nov 14, 2023	BUY	$48.35 - $61.26 $4.43 Million - $5.62 Million	91,692 Added 100.31%	183,105 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$19.01 - $51.79 $352,882 - $961,377	18,563 Added 25.48%	91,413 $4.66 Million
Q1 2023 May 15, 2023	BUY	$11.03 - $23.7 $803,535 - $1.73 Million	72,850 New	72,850 $1.56 Million

124

58.2M

52.2K

38K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $2.14B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.